Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
PLoS One ; 18(6): e0276473, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37307279

RESUMEN

BACKGROUND: Antiretroviral therapy (ART) decreases perinatal HIV transmission, but concerns exist regarding maternal and infant safety. We compared the incidence of congenital malformations and other adverse outcomes in pregnancies exposed to integrase inhibitor (INSTI) versus non-INSTI ART. SETTING: Single-site review of all pregnancies among women living with HIV between 2008 and 2018. METHODS: We used binomial family generalized estimating equations to model the relationship of congenital anomalies and pregnancy outcomes with exposure to INSTI or dolutegravir (DTG) versus non-INSTI ART. RESULTS: Among 257 pregnancies, 77 women received ≥1 INSTI (54 DTG, 14 elvitegravir, 15 raltegravir), 167 received non-INSTI, and 3 had missing data. Fifty congenital anomalies were identified in 36 infants. Infants with first-trimester DTG or any first-trimester INSTI exposure had higher odds of congenital anomalies than infants with first-trimester non-INSTI exposure (OR = 2.55; 95%CI = 1.07-6.10; OR = 2.61; 95%CI = 1.15-5.94, respectively). Infants with INSTI exposure after the second trimester had no increased odds of anomalies. Women with INSTI exposure had higher odds of preeclampsia (OR = 4.73; 95%CI = 1.70-13.19). Among women who received INSTI, grade ≥3 laboratory abnormalities were noted in 2.6% while receiving the INSTI and 3.9% while not receiving the INSTI, versus 16.2% in women who received non-INSTI. There was no association between INSTI exposure and other pregnancy outcomes. CONCLUSION: In our cohort, first-trimester INSTI exposure was associated with increased rates of congenital anomalies and use of INSTI during pregnancy was associated with preeclampsia. These findings underscore the need for continued monitoring of the safety of INSTI in pregnancy.


Asunto(s)
Anomalías Inducidas por Medicamentos , Inhibidores de Integrasa VIH , Exposición Materna , Lactante , Infecciones por VIH/tratamiento farmacológico , Inhibidores de Integrasa VIH/efectos adversos , Inhibidores de Integrasa VIH/uso terapéutico , Exposición Materna/efectos adversos , Anomalías Inducidas por Medicamentos/epidemiología , Primer Trimestre del Embarazo , Preeclampsia/inducido químicamente , Antirretrovirales/efectos adversos , Estudios Retrospectivos , Estudios de Cohortes , Humanos , Masculino , Femenino , Embarazo , Recién Nacido
2.
J Immunol ; 195(11): 5452-60, 2015 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-26500346

RESUMEN

Igs in vertebrates comprise equally sized H and L chains, with exceptions such as H chain-only Abs in camels or natural Ag receptors in sharks. In Reptilia, Igs are known as IgYs. Using immunoassays with isotype-specific mAbs, in this study we show that green turtles (Chelonia mydas) have a 5.7S 120-kDa IgY comprising two equally sized H/L chains with truncated Fc and a 7S 200-kDa IgY comprised of two differently sized H chains bound to L chains and apparently often noncovalently associated with an antigenically related 90-kDa moiety. Both the 200- and 90-kDa 7S molecules are made in response to specific Ag, although the 90-kDa molecule appears more prominent after chronic Ag stimulation. Despite no molecular evidence of a hinge, electron microscopy reveals marked flexibility of Fab arms of 7S and 5.7S IgY. Both IgY can be captured with protein G or melon gel, but less so with protein A. Thus, turtle IgY share some characteristics with mammalian IgG. However, the asymmetrical structure of some turtle Ig and the discovery of an Ig class indicative of chronic antigenic stimulation represent striking advances in our understanding of immunology.


Asunto(s)
Isotipos de Inmunoglobulinas/inmunología , Inmunoglobulinas/inmunología , Inmunoglobulinas/ultraestructura , Tortugas/inmunología , Animales , Anticuerpos/inmunología , Anticuerpos Antiidiotipos/inmunología , Anticuerpos Monoclonales/inmunología , Antígenos/inmunología , Procesamiento de Imagen Asistido por Computador , Cadenas Pesadas de Inmunoglobulina/inmunología , Cadenas Ligeras de Inmunoglobulina/inmunología , Microscopía Electrónica de Transmisión/veterinaria , Datos de Secuencia Molecular , Receptores Fc/inmunología
4.
Am J Perinatol ; 32(5): 461-8, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25262455

RESUMEN

OBJECTIVE: To determine whether hyperglycemic excursions detected by continuous glucose monitoring (CGM) correlate with birth weight percentile and other pregnancy outcomes, and whether CGM correlates better with these outcomes than a single glucose value from a 1-hour glucose challenge test (GCT). STUDY DESIGN: This was a prospective observational study of 55 pregnant patients without preexisting diabetes, who wore a CGM device for up to 7 days, between 24 and 28 weeks' gestation. The area under the curve (AUC) of hyperglycemic excursions above various thresholds (110, 120, 130, 140, and 180 mg/dL) was calculated. These AUC values, and results from a standard 50-g GCT, were correlated with our primary outcome of birth weight percentile, and secondary outcomes of unplanned operative delivery, pregnancy complications, delivery complications, fetal complications, and neonatal complications. RESULTS: A consistent correlation was seen between all AUC thresholds and birth weight percentile (r = 0.29, p < 0.05 for AUC-110, -120, -130, and -140; r = 0.25, p = 0.07 for AUC-180). This correlation was stronger than that of 1-hour oral GCT (r = -0.02, p = 0.88). There was no association between AUC values and other outcomes. CONCLUSIONS: Among nondiabetic pregnant patients, hyperglycemic excursions detected by CGM show a stronger correlation to birth weight percentile than blood glucose values obtained 1-hour after a 50-g oral GCT.


Asunto(s)
Peso al Nacer , Glucemia/análisis , Hiperglucemia/diagnóstico , Complicaciones del Embarazo/diagnóstico , Resultado del Embarazo , Adulto , Área Bajo la Curva , Parto Obstétrico , Diabetes Gestacional/diagnóstico , Femenino , Macrosomía Fetal , Edad Gestacional , Prueba de Tolerancia a la Glucosa , Humanos , Monitoreo Fisiológico , Embarazo , Estudios Prospectivos , Factores de Riesgo , Adulto Joven
5.
J Pharm Sci ; 104(2): 750-9, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25231267

RESUMEN

Aggregation of protein-based therapeutics is a challenging problem in the biopharmaceutical industry. Of particular concern are implications for product efficacy and clinical safety because of potentially increased immunogenicity of the aggregates. We used transmission electron microscopy (TEM) to characterize biophysical and morphological features of antibody aggregates formed upon controlled environmental stresses. TEM results were contrasted with results obtained in parallel by independent methods, including size-exclusion chromatography, dynamic light scattering, microflow imaging, and nanoparticle tracking. For TEM, stressed samples were imaged by negative staining and in the frozen-hydrated state. In both cases, aggregates appeared amorphous but differed in fine structural detail. Specifically, negatively stained aggregates were compact and consisted of smaller globular structures that had a notable three-dimensional character. Elements of the native IgG structure were retained, suggesting that the aggregates were not assembled from denatured protein. In contrast, aggregates in frozen-hydrated samples appeared as extended, branched protein networks with large surface area. Using multiple scales of magnification, a wide range of particle sizes was observed and semiquantitatively characterized. The detailed information provided by TEM extended observations obtained with the independent methods, demonstrating the suitability of TEM as a complementary approach to submicron particle analysis.


Asunto(s)
Inmunoglobulinas Intravenosas/química , Inmunoglobulinas Intravenosas/ultraestructura , Microscopía Electrónica de Transmisión/métodos , Agregado de Proteínas , Tamaño de la Partícula , Agregado de Proteínas/fisiología
6.
Am J Perinatol ; 30(2): 143-8, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24915559

RESUMEN

OBJECTIVE: This study aims to describe the pattern of maternal glucose response to betamethasone administration using a continuous glucose monitoring system. STUDY DESIGN: A prospective observational trial was conducted among women receiving clinically indicated betamethasone between 24 and 34 weeks gestation. At the time of initial betamethasone administration, a continuous glucose monitoring device was inserted which measured interstitial fluid glucose levels every 5 minutes. Glucose levels were monitored for 7 days, until delivery, or until hospital discharge, whichever came first. We recorded the percentage of time women spent above three glucose thresholds: 110, 144, and 180 mg/dL, respectively. RESULTS: A total of 17 women were enrolled at the time of betamethasone administration and data were available for 15 patients. There were 11 nondiabetic and 4 diabetic women. Both diabetic and nondiabetic women had the highest recorded blood glucose readings between 24 and 48 hours after the first injection of betamethasone. In that period, nondiabetic women spent 73, 40, and 17% of the time with blood glucose levels above the 110, 144, and 180 mg/dL thresholds, respectively. CONCLUSION: Nondiabetic women receiving betamethasone manifest significant hyperglycemia after betamethasone administration. If delivery is imminent, maternal glucose response to betamethasone may need to be monitored to prevent possible neonatal hypoglycemia.


Asunto(s)
Betametasona/efectos adversos , Glucemia/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Gestacional/metabolismo , Glucocorticoides/efectos adversos , Hiperglucemia/inducido químicamente , Embarazo en Diabéticas/metabolismo , Nacimiento Prematuro , Adulto , Automonitorización de la Glucosa Sanguínea , Estudios de Casos y Controles , Estudios de Cohortes , Diabetes Mellitus Tipo 2/complicaciones , Femenino , Humanos , Hiperglucemia/metabolismo , Embarazo , Estudios Prospectivos , Adulto Joven
7.
J Clin Invest ; 124(11): 4941-52, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25329693

RESUMEN

There is strong evidence that overproduction of soluble fms-like tyrosine kinase-1 (sFLT1) in the placenta is a major cause of vascular dysfunction in preeclampsia through sFLT1-dependent antagonism of VEGF. However, the cause of placental sFLT1 upregulation is not known. Here we demonstrated that in women with preeclampsia, sFLT1 is upregulated in placental trophoblasts, while VEGF is upregulated in adjacent maternal decidual cells. In response to VEGF, expression of sFlt1 mRNA, but not full-length Flt1 mRNA, increased in cultured murine trophoblast stem cells. We developed a method for transgene expression specifically in mouse endometrium and found that endometrial-specific VEGF overexpression induced placental sFLT1 production and elevated sFLT1 levels in maternal serum. This led to pregnancy losses, placental vascular defects, and preeclampsia-like symptoms, including hypertension, proteinuria, and glomerular endotheliosis in the mother. Knockdown of placental sFlt1 with a trophoblast-specific transgene caused placental vascular changes that were consistent with excess VEGF activity. Moreover, sFlt1 knockdown in VEGF-overexpressing animals enhanced symptoms produced by VEGF overexpression alone. These findings indicate that sFLT1 plays an essential role in maintaining vascular integrity in the placenta by sequestering excess maternal VEGF and suggest that a local increase in VEGF can trigger placental overexpression of sFLT1, potentially contributing to the development of preeclampsia and other pregnancy complications.


Asunto(s)
Endometrio/enzimología , Placenta/enzimología , Preeclampsia/enzimología , Factor A de Crecimiento Endotelial Vascular/fisiología , Receptor 1 de Factores de Crecimiento Endotelial Vascular/metabolismo , Animales , Estudios de Casos y Controles , Inducción Enzimática , Femenino , Expresión Génica , Masculino , Ratones , Embarazo , Receptor 1 de Factores de Crecimiento Endotelial Vascular/genética
8.
Int J Nanomedicine ; 9: 1367-77, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24648734

RESUMEN

Development of lipid-based adjuvant formulations to enhance the immunogenicity of recombinant vaccine antigens is a focus of modern vaccine research. Characterizing interactions between vaccine antigens and formulation excipients is important for establishing compatibility between the different components and optimizing vaccine stability and potency. Cryogenic transmission electron microscopy (TEM) is a highly informative analytical technique that may elucidate various aspects of protein- and lipid-based structures, including morphology, size, shape, and phase structure, while avoiding artifacts associated with staining-based TEM. In this work, cryogenic TEM is employed to characterize a recombinant tuberculosis vaccine antigen, an anionic liposome formulation, and antigen-liposome interactions. By performing three-dimensional tomographic reconstruction analysis, the formation of a population of protein-containing flattened liposomes, not present in the control samples, was detected. It is shown that cryogenic TEM provides unique information regarding antigen-liposome interactions not detectable by light-scattering-based methods. Employing a suite of complementary analytical techniques is important to fully characterize interactions between vaccine components.


Asunto(s)
Antígenos Bacterianos/química , Vacunas contra la Tuberculosis/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Animales , Antígenos Bacterianos/ultraestructura , Microscopía por Crioelectrón , Humanos , Imagenología Tridimensional , Liposomas/administración & dosificación , Liposomas/química , Nanomedicina , Nanopartículas/administración & dosificación , Nanopartículas/química , Tamaño de la Partícula , Vacunas contra la Tuberculosis/administración & dosificación , Vacunas contra la Tuberculosis/química , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/química , Vacunas Sintéticas/inmunología
9.
Pediatr Radiol ; 44(2): 230-3, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24042433

RESUMEN

Cloacal malformations are a spectrum of congenital pelvic malformations that result from abnormal cloacal division during early embryogenesis. Depending on the timing of the developmental arrest, a spectrum of abnormalities can result, ranging from urogenital sinus malformations to cloacal dysgenesis. This case highlights the unique imaging features of cloacal dysgenesis, which is an extremely rare variant of this malformation spectrum. This variant is also the most severe manifestation of the cloacal malformation spectrum.


Asunto(s)
Anomalías Múltiples/diagnóstico , Anomalías Múltiples/embriología , Cloaca/anomalías , Cloaca/patología , Imagen por Resonancia Magnética/métodos , Ultrasonografía Prenatal/métodos , Adolescente , Cloaca/diagnóstico por imagen , Cloaca/embriología , Diagnóstico Diferencial , Femenino , Humanos , Embarazo
10.
Reprod Toxicol ; 45: 1-7, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24373932

RESUMEN

Identification of maternal environmental factors influencing preterm birth risks is important to understand the reasons for the increase in prematurity since 1990. Here, we utilized a health survey, the US National Health and Nutrition Examination Survey (NHANES) to search for personal environmental factors associated with preterm birth. 201 urine and blood markers of environmental factors, such as allergens, pollutants, and nutrients were assayed in mothers (range of N: 49-724) who answered questions about any children born preterm (delivery <37 weeks). We screened each of the 201 factors for association with any child born preterm adjusting by age, race/ethnicity, education, and household income. We attempted to verify the top finding, urinary bisphenol A, in an independent study of pregnant women attending Lucile Packard Children's Hospital. We conclude that the association between maternal urinary levels of bisphenol A and preterm birth should be evaluated in a larger epidemiological investigation.


Asunto(s)
Compuestos de Bencidrilo/orina , Contaminantes Ambientales/orina , Estrógenos no Esteroides/orina , Exposición Materna/efectos adversos , Fenoles/orina , Nacimiento Prematuro/etiología , Adulto , Compuestos de Bencidrilo/sangre , Monitoreo del Ambiente , Contaminantes Ambientales/sangre , Estrógenos no Esteroides/sangre , Femenino , Humanos , Encuestas Nutricionales , Fenoles/sangre , Embarazo , Adulto Joven
11.
MAbs ; 5(3): 364-72, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23572180

RESUMEN

A dual-specific, tetravalent immunoglobulin G-like molecule, termed dual variable domain immunoglobulin (DVD-Ig™), is engineered to block two targets. Flexibility modulates Fc receptor and complement binding, but could result in undesirable cross-linking of surface antigens and downstream signaling. Understanding the flexibility of parental mAbs is important for designing and retaining functionality of DVD-Ig™ molecules. The architecture and dynamics of a DVD-Ig™ molecule and its parental mAbs was examined using single particle electron microscopy. Hinge angles measured for the DVD-Ig™ molecule were similar to the inner antigen parental mAb. The outer binding domain of the DVD-Ig™ molecule was highly mobile and three-dimensional (3D) analysis showed binding of inner antigen caused the outer domain to fold out of the plane with a major morphological change. Docking high-resolution X-ray structures into the 3D electron microscopy map supports the extraordinary domain flexibility observed in the DVD-Ig™ molecule allowing antigen binding with minimal steric hindrance.


Asunto(s)
Anticuerpos Biespecíficos/química , Anticuerpos Monoclonales/química , Inmunoglobulina G/química , Región Variable de Inmunoglobulina/química , Inmunoterapia , Anticuerpos Monoclonales/uso terapéutico , Antígenos/inmunología , Cristalografía por Rayos X , Humanos , Interleucina-12/química , Interleucina-12/inmunología , Interleucina-18/química , Interleucina-18/inmunología , Microscopía Electrónica de Transmisión , Unión Proteica , Ingeniería de Proteínas/métodos , Estructura Terciaria de Proteína
13.
J Diabetes Sci Technol ; 6(6): 1478-85, 2012 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-23294795

RESUMEN

Current treatment of diabetes in pregnancy relies on intermittent self-monitoring of blood glucoses using finger sticks to monitor capillary blood glucoses. Continuous glucose monitoring (CGM) systems are an emerging technology that allow frequent glucose measurements (every 5 min) and the ability to monitor glucose trends in real time. Although these devices are currently expensive and mildly invasive to use, there is huge potential for their use in both the research and clinical realms. From a research perspective, there is the potential to better understand glucose metabolism in pregnancy, both in patients with and without diabetes. For the treating clinician, CGM has the potential to improve detection of hyperglycemic excursions as well as asymptomatic hypoglycemia and the data to improve management of glucose levels in diabetes patients. In this article, we review current literature examining use of CGM in both research and clinical applications.


Asunto(s)
Automonitorización de la Glucosa Sanguínea/métodos , Automonitorización de la Glucosa Sanguínea/tendencias , Glucemia/análisis , Complicaciones del Embarazo , Femenino , Humanos , Embarazo
14.
J Clin Endocrinol Metab ; 96(7): E1148-52, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21525162

RESUMEN

OBJECTIVES: Recent studies have found dysregulation in circulating levels of a number of angiogenic factors and their soluble receptors in preeclampsia. In this study, we examined the mechanism of production of soluble Tie2 (sTie2) and its potential connection to the failure of vascular remodeling in preeclamptic pregnancies. DESIGN/SETTING/PATIENTS: Serum samples were collected prospectively from 41 pregnant subjects at five different time points throughout pregnancy. Five of these subjects developed preeclampsia. For a second study, serum and placental samples were collected at delivery from preeclamptic and gestational age-matched controls. We examined serum sTie2 levels, and angiopoietin 1, angiopoietin 2, and Tie2 mRNA expression and localization in placental samples from the central basal plate area. We also examined the effects of vascular endothelial growth factor (VEGF) and a matrix metalloproteinase (MMP) inhibitor on proteolytic shedding of Tie2 in uterine microvascular endothelial cells. RESULTS: Serum sTie2 levels were significantly lower in preeclamptic subjects starting at 24-28 wk of gestation and continued to be lower through the time of delivery. In culture experiments, VEGF treatment significantly increased sTie2 levels in conditioned media, whereas the MMP inhibitor completely blocked this increase, suggesting that VEGF-induced Tie2 release is MMP dependent. CONCLUSIONS: Our data suggest, for the first time, an interaction between VEGF and Tie2 in uterine endothelial cells and a potential mechanism for the decrease in circulating sTie2 levels in preeclampsia, likely through inhibition of VEGF signaling. Further studies on VEGF-Tie2 interactions during pregnancy should provide new insights into the mechanisms underlying the failure of vascular remodeling in preeclampsia and other pregnancy complications.


Asunto(s)
Células Endoteliales/metabolismo , Preeclampsia/metabolismo , Receptor TIE-2/sangre , Transducción de Señal/fisiología , Factor A de Crecimiento Endotelial Vascular/metabolismo , Adulto , Células Cultivadas , Medios de Cultivo Condicionados , Células Endoteliales/citología , Femenino , Humanos , Metaloproteinasas de la Matriz/metabolismo , Embarazo , Útero/citología , Útero/metabolismo
16.
Obstet Gynecol ; 113(2 Pt 2): 491-492, 2009 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19155931

RESUMEN

BACKGROUND: Stercoral perforation of the colon is a rarely reported disease with high mortality rate. Our literature review identified one prior case reported during pregnancy, with mortality in both mother and infant. CASE: A nulliparous female presented at 36 weeks of gestation with fever, tachycardia, and severe abdominal pain. She delivered by cesarean when purulent ascites and stercoral perforation of the sigmoid colon were discovered. After a sigmoid resection with end colostomy, she and her infant recovered uneventfully. CONCLUSION: Stercoral perforation of the colon is rare in pregnancy. Prompt surgical treatment is necessary. Surgical exploration may be warranted in the pregnant patient with unexplained abdominal pain.


Asunto(s)
Cesárea , Impactación Fecal/complicaciones , Perforación Intestinal/etiología , Complicaciones del Embarazo , Enfermedades del Sigmoide/etiología , Colostomía , Femenino , Humanos , Recién Nacido , Embarazo , Tercer Trimestre del Embarazo
17.
Am J Obstet Gynecol ; 197(3): 306.e1-5, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17826431

RESUMEN

OBJECTIVE: We hypothesized that prolonged second stage of labor increases the incidence of unintentional hysterotomy extensions at cesarean delivery. STUDY DESIGN: A retrospective cohort of term pregnant women who underwent primary cesarean delivery after failed second stage of labor at Stanford University was assessed for hysterotomy extensions and other maternal and neonatal morbidities. Groups included second stage length of 1-3 hours and >4 hours. Data were analyzed with the use of chi-square and Fisher's exact tests. RESULTS: Of the 239 women who were studied, the second stage of labor lasted 1-3 hours in 82 patients and >4 hours in 157 patients. Prolonged second stage of labor was associated with unintentional hysterotomy extensions (40% vs 26%; P = .03), particularly to the cervix (29% vs 5%; P = .005), and with surgery that lasted >90 minutes (9% vs 1%; P = .01). The incidence of hysterotomy extensions was associated positively with the length of the second stage. Other maternal and neonatal morbidities were similar between groups. CONCLUSION: Prolonged second stage of labor is associated with an increase in unintentional hysterotomy extensions at cesarean delivery and prolonged operative time. The future risk of hysterotomy extensions merits further investigation.


Asunto(s)
Cesárea , Segundo Periodo del Trabajo de Parto , Complicaciones del Trabajo de Parto/fisiopatología , Esfuerzo de Parto , Adulto , Cesárea/métodos , Femenino , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Estudios Retrospectivos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...